Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Shareholder vote
confidence 98%
filed 2026-06-03
Item 5.07
This is a classic Item 5.07 disclosure reporting the final voting results from Bright Horizons' annual meeting of shareholders held on June 3, 2026. The filing presents tabulated results for three proposals: election of six directors, advisory vote on named executive officer compensation, and ratification of Deloitte & Touche LLP as independent auditor. All proposals passed with substantial majorities, making this a material shareholder governance event.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-03
Item 5.07
This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting of Stockholders held on June 2, 2026, filed under Item 5.07. The filing reports voting outcomes on four proposals: election of Class III Directors (Paul Oroian, Virginia Prodan, Pandji Putra, and Robert Dunn), ratification of RBSM, LLP as auditors, approval of named executive officer compensation, and frequency of future advisory votes on compensation. These are standard annual meeting matters that materially affect corporate governance and investor interests.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-03
Item 5.07
This is a clear disclosure of shareholder vote results from Mannatech's 2026 Annual Shareholders' Meeting held on June 2, 2026. The filing reports voting outcomes on three proposals: election of directors (John A. Seifrick and Robert Toth as Class III directors), ratification of BDO USA, P.C. as independent auditor, and advisory approval of executive compensation. The detailed vote tallies and broker non-votes are presented in tabular form, which is the standard format for Item 5.07 disclosures of shareholder meeting results.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-03
Item 5.07
This Item 5.07 filing discloses the results of CEVA's June 2, 2026 annual stockholder meeting, including voting outcomes for three proposals: election of seven directors, advisory approval of named executive officer compensation, and ratification of independent auditors. The detailed vote tallies (votes for, against, abstentions, and broker non-votes) for each proposal are the core disclosure, which is the defining characteristic of shareholder_vote_results.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-03
Item 5.07
This is a clear disclosure of shareholder voting results from Kingfish Holding Corporation's 2026 Annual Meeting of Stockholders held on June 1, 2026. The filing reports final vote tabulations for two proposals: (1) election of eight directors, all of whom received 100% approval with 771,497 votes for and zero against, and (2) ratification of Astra Audit & Advisory LLC as independent auditors, also approved unanimously. This is a standard Item 5.07 shareholder vote results disclosure that is material to investors as it confirms board composition and auditor selection.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-03
The filing discloses results of InspireMD's 2026 annual meeting of stockholders held on June 3, 2026, with detailed voting tallies for three proposals: election of three directors (Marvin Slosman, Raymond Cohen, Dan Dearen), approval of an amendment to increase authorized common shares from 150M to 250M, and ratification of Kesselman & Kesselman as independent auditors. Item 5.07 explicitly presents the voting results with vote counts and percentages, which is the defining characteristic of shareholder_vote_results. The increase in authorized shares is material as it affects potential dilution and capital structure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-03
Item 5.07 discloses the submission of matters to a vote of security holders. The filing reports that majority stockholders (Hai Shi and Ying Zhou, holding 95% voting power) delivered written consent on June 2, 2026, approving an amendment to the Certificate of Incorporation to effect a reverse stock split at a ratio of 1-for-2 to 1-for-10. This is a material corporate action requiring stockholder approval that would affect all shareholders' equity positions.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-03
The filing discloses results of Stardust Power Inc.'s 2026 Annual Meeting of Stockholders held on June 2, 2026, under Item 5.07. The company reports voting outcomes on five proposals including director elections, auditor ratification, equity issuance approval, certificate amendment, and equity plan amendment. The approval of the amended 2024 Equity Incentive Plan (increasing shares by 2.6 million and extending the term to 2036) is material to investors as it affects dilution and executive compensation capacity.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-03
Item 5.07
This Item 5.07 discloses the results of an extraordinary general meeting held on May 28, 2026, where shareholders voted on two substantive proposals: (1) the Extension Amendment Proposal to extend the business combination deadline from June 19, 2026 to December 19, 2026, and (2) the Trust Agreement Amendment Proposal to amend the investment management trust agreement to permit such extensions. Both proposals were approved unanimously (2,291,094 votes for, 0 against, 0 abstentions), with 83.67% of outstanding shares represented. The extension of the termination date is material to investors as it directly affects the timeline and likelihood of the Company completing its initial business combination.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-03
Item 5.07
This Item 5.07 discloses the results of Artisan Partners' 2026 annual stockholder meeting held on June 3, 2026, including voting outcomes on three matters: election of nine directors, advisory vote on named executive officer compensation, and ratification of PricewaterhouseCoopers LLP as independent auditor. The detailed vote tallies (For, Against, Abstain, Broker Non-Votes) for each proposal are the core disclosure required by Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-03
Item 5.07
Bristow Group Inc. held its Annual Meeting on June 3, 2026, at which shareholders voted on four proposals: election of nine directors, advisory approval of named executive officer compensation, approval of Amendment No. 4 to the 2021 Equity Incentive Plan, and ratification of KPMG LLP as independent auditors. All four proposals passed with substantial majorities.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-03
Item 5.07
OUTFRONT Media held its Annual Meeting on June 3, 2026, with shareholders voting on four matters: election of nine directors, ratification of PricewaterhouseCoopers LLP as auditor, a say-on-pay advisory vote, and approval of an Amended and Restated Omnibus Stock Incentive Plan increasing the share reserve by 3,373,000 shares. All four proposals passed with substantial majorities.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-03
Item 5.07
NextDecade held its 2026 Annual Meeting of Stockholders on June 3, 2026, with shareholders approving all four proposals: election of six directors (two Class B and four Class C), amendment to the 2017 Omnibus Incentive Plan to increase available shares, advisory vote on named executive officer compensation, and ratification of KPMG LLP as independent auditors.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-03
Item 5.07
Zillow Group held its 2026 Annual Meeting of Shareholders on June 2, 2026, with certified voting results showing election of three Class III directors (Bohutinsky, Hoag, and Maffei) and ratification of Deloitte & Touche LLP as independent auditor.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-03
Item 5.07
This is a clear disclosure of shareholder voting results from the 2026 Annual Meeting of Shareholders held on June 3, 2026. The filing reports the outcomes of three proposals: election of ten directors, advisory approval of named executive officer compensation, and appointment of KPMG LLP as auditors. The detailed vote tallies (votes for, against, abstain/withheld, and broker non-votes) for each nominee and proposal are the hallmark of Item 5.07 shareholder vote results disclosures, which are material to investors assessing corporate governance and shareholder sentiment.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-03
Item 5.07
This is a clear disclosure of shareholder voting results from the 2026 Annual Meeting of Shareholders held on June 3, 2026. The filing reports the outcomes of three proposals: election of ten directors, advisory approval of named executive officer compensation, and appointment of KPMG LLP as auditors. The detailed voting tallies (votes for, against, abstain/withheld, and broker non-votes) for each proposal are the hallmark of Item 5.07 shareholder vote results disclosures, which are material to investors assessing corporate governance and shareholder support for management.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-03
Item 5.07
This is a clear disclosure of shareholder voting results from Crescent Biopharma's June 2, 2026 annual general meeting, filed under Item 5.07. The filing reports detailed vote tallies for four proposals: election of two Class II directors (Jonathan Violin, Ph.D. and Susan Moran, M.D., MSCE), ratification of PricewaterhouseCoopers LLP as independent auditor, advisory approval of named executive officer compensation, and advisory vote on compensation vote frequency. All proposals passed. This is material as director elections and auditor ratification directly affect corporate governance and investor confidence.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-03
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from the Company's May 28, 2026 annual meeting. The filing reports final voting tallies for three proposals: election of two Class II directors (William A. Heyburn and Andrew Lauck), ratification of Deloitte & Touche LLP as independent auditor, and advisory approval of named executive officer compensation. All three votes passed with substantial majorities, making this a routine but material governance disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-03
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Agilon Health's annual meeting of stockholders held on June 2, 2026. The filing presents voting outcomes for three proposals: election of three Class II directors (Diana McKenzie, Karen McLoughlin, Ronald Williams), ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. All three proposals passed with substantial majorities, making this a routine but material shareholder governance disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-03
Item 5.07
This is a clear disclosure of shareholder vote results from Acumen Pharmaceuticals' June 3, 2026 annual meeting, covering three proposals: election of three Class II directors, ratification of Ernst & Young LLP as independent auditor, and approval of the Amended and Restated 2021 Equity Incentive Plan. The filing presents detailed voting tallies for each proposal, which is the hallmark of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-03
Item 5.07
This is a clear disclosure of shareholder voting results from FGI Industries' Annual General Meeting held on June 3, 2026. The filing presents tabulated vote counts for two matters: (1) election of five directors (David Bruce, John Chen, Todd Heysse, Kellie Zesch Weir, and Anagha Apte), and (2) ratification of Marcum Asia CPAs LLP as independent auditor. All five director nominees were elected with overwhelming support (1,387,347–1,387,581 votes for, zero against), and the auditor ratification passed with 1,606,497 votes for. This is a textbook Item 5.07 shareholder vote results disclosure, material to investors as it confirms board composition and auditor appointment.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-03
Item 5.07
This is a clear disclosure of shareholder voting results from Global Industrial Company's 2026 Annual Meeting of Stockholders held on June 1, 2026. Item 5.07 requires disclosure of the final voting results for all matters submitted to shareholders, including election of eight directors, ratification of Ernst & Young LLP as auditor, advisory vote on named executive officer compensation, and approval of the Amended and Restated 2018 Employee Stock Purchase Plan. The filing presents detailed vote tallies (For, Against, Abstain, Broker Non-Votes) for each matter, which is the standard format for shareholder vote result disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-03
Item 5.07
This is a clear disclosure of shareholder vote results from Keros Therapeutics' 2026 Annual Meeting of Stockholders held on June 3, 2026. The filing reports final voting tallies for three proposals: election of two directors (Proposal 1), ratification of Deloitte & Touche LLP as auditor (Proposal 2), and advisory approval of executive compensation (Proposal 3), with specific vote counts for each. This is a quintessential Item 5.07 shareholder_vote_results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-03
Item 5.07
Valion Bio held its Annual Meeting of Stockholders on May 28, 2026, with shareholders voting on eight proposals including director elections, an amendment to the 2021 Equity Incentive Plan increasing authorized shares by 2,581,608, auditor ratification, and four Nasdaq Rule 5635(d) approvals for dilutive equity issuances to institutional investors and Tumim Stone Capital. All proposals passed.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-03
Item 5.07
This Item 5.07 disclosure reports the final voting results from Brighthouse Financial's June 2, 2026 Annual Meeting of Stockholders, covering three proposals: election of nine directors, ratification of Deloitte & Touche LLP as independent auditor, and an advisory say-on-pay vote. The detailed tabulation of votes for and against each director nominee and the three proposals is the core content of a shareholder vote results disclosure, which is material to investors assessing board composition and governance outcomes.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-03
Item 5.07
STEM held its 2026 Annual Meeting on June 3, 2026, with shareholders voting on four proposals: election of three Class II directors, approval of an amended equity incentive plan with 425,000 additional shares, advisory approval of named executive officer compensation, and ratification of RSM US LLP as independent auditor. Detailed voting results are disclosed for each proposal.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-03
Item 5.07
This is a textbook Item 5.07 disclosure of shareholder vote results from Grocery Outlet's June 1, 2026 annual meeting. The filing reports voting outcomes on four matters: (1) re-election of ten directors with detailed vote tallies, (2) ratification of Deloitte & Touche LLP as independent auditor, (3) advisory vote on named executive officer compensation, and (4) frequency of future advisory votes on executive compensation. All four proposals passed with substantial majorities. Shareholder vote results are material to investors as they reflect governance outcomes and stakeholder approval of key corporate matters.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-03
Item 5.07
This is a clear disclosure of shareholder vote results from UWM Holdings' Annual Meeting of Stockholders held on June 3, 2026. The filing reports voting outcomes for three proposals: election of four directors, ratification of Deloitte & Touche as independent auditor, and advisory approval of named executive officer compensation. All three proposals passed with substantial majorities, and the detailed vote tallies are provided for each director nominee and proposal.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-03
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Robinhood's 2026 Annual Meeting of Stockholders held on June 2, 2026. The filing presents voting results for three proposals: election of ten directors, advisory approval of named executive officer compensation, and ratification of Ernst & Young LLP as independent auditor. All three proposals passed with substantial majorities, making this a material shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-03
Item 5.07
This is a clear disclosure of shareholder vote results from Torrid Holdings' June 2, 2026 annual meeting, including election of directors (Theophlius Killion and Michael A. Shaffer), advisory approval of named executive officer compensation, and ratification of PricewaterhouseCoopers LLP as independent auditor. The filing presents detailed voting tallies for each proposal, which is the hallmark of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-03
Item 5.07
This Item 5.07 disclosure reports the final voting results from Rush Street Interactive's June 3, 2026 annual meeting of stockholders on three matters: election of four Class III directors, ratification of WithumSmith+Brown, PC as independent auditor, and approval of Charter Amendments. The detailed vote tallies for each proposal are the core content of the filing, which is the defining characteristic of a shareholder_vote_results event.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-03
Item 5.07
This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting of Stockholders held on June 3, 2026. The filing reports voting outcomes for two proposals: (1) election of Class II directors Douglas G. Forsyth and Kimberly Manhard, and (2) ratification of BDO USA, P.C. as the independent auditor. The detailed vote tallies (votes for, against, withheld, abstained, and broker non-votes) are the hallmark of Item 5.07 disclosures and are material to investors assessing board composition and audit oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-02
Item 5.07
This is a clear disclosure of shareholder voting results from Lowe's annual meeting held May 29, 2026, covering six proposals: election of 12 directors, advisory vote on named executive officer compensation, ratification of Deloitte & Touche LLP as independent auditor, and three shareholder proposals. The filing presents final vote tallies for each proposal, which is the quintessential content of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-02
Item 5.07
Mattel held its Annual Meeting of Shareholders and disclosed voting results on multiple proposals: election of all ten director nominees by majority vote, ratification of PricewaterhouseCoopers LLP as independent auditor, advisory approval of named executive officer compensation, and approval of the 2026 Restatement of the 2010 Equity and Long-Term Compensation Plan.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 99%
filed 2026-06-02
Item 5.07
This is a clear Item 5.07 disclosure of shareholder voting results from Gartner's 2026 Annual Meeting held on May 28, 2026. The filing reports detailed vote tallies for three proposals: election of thirteen board directors, advisory approval of named executive officer compensation, and ratification of KPMG LLP as independent auditor. Shareholder vote results are material to investors as they reflect governance outcomes and stakeholder approval of key corporate matters.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-02
Item 5.07
The Buckle held its Annual Meeting of Stockholders on June 1, 2026, with shareholders voting on four proposals: election of 12 directors, ratification of Deloitte & Touche LLP as auditor, advisory vote on executive compensation, and advisory vote on compensation vote frequency. Detailed voting tallies for each proposal and director were disclosed.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-02
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from ADC Therapeutics' 2026 annual general meeting held on June 1, 2026. The filing presents detailed voting tallies for 12 proposals, including director reelections, compensation approvals, auditor reelection, and amendments to the articles of association. All proposals were approved. This is material as it documents shareholder approval of key governance matters, executive compensation, and capital structure amendments.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-02
Item 5.07
This is a clear disclosure of shareholder voting results from Booking Holdings' 2026 Annual Meeting held on June 2, 2026. The filing reports the outcomes of six proposals including election of 11 directors, advisory vote on executive compensation, auditor ratification, certificate of incorporation amendment, and two stockholder proposals. This is a quintessential Item 5.07 disclosure and is material as it documents the composition of the board and shareholder approval of key governance matters.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-02
Item 5.07
This is a clear disclosure of shareholder vote results from the Company's May 28, 2026 annual meeting of stockholders. The filing reports voting outcomes for four proposals: election of five directors (Proposal No. 1), ratification of the independent auditor Salberg & Company, P.A. (Proposal No. 2), and election of Frank D. Recker to the board (Proposal No. 4), with detailed vote tallies for each matter. This is the quintessential Item 5.07 disclosure and is material to investors as it reflects the composition of the board and auditor approval.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-02
Item 5.07
This Item 5.07 disclosure reports the results of Janus Henderson's 2026 Annual General Meeting held on May 29, 2026, including voting outcomes on five proposals: election of 11 directors, approval of non-executive director compensation cap increase, advisory say-on-pay vote on executive compensation, renewal of share repurchase authority, and reappointment of PricewaterhouseCoopers as auditor. The detailed voting tallies and percentages are the core content of this filing, which is the quintessential shareholder_vote_results event type.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-02
Item 5.07
Dollar General's Annual Meeting of Shareholders held on May 28, 2026 resulted in shareholder approval of the election of nine directors and ratification of Ernst & Young LLP as independent auditor, and rejection of three shareholder proposals, with tabulated vote counts disclosed for all six proposals.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-02
Item 5.07
This is a clear disclosure of shareholder vote results from the Annual Meeting of Shareholders held on June 1, 2026. The filing reports voting outcomes on three matters: (1) election of seven directors with individual vote tallies, (2) ratification of Crowe LLP as independent auditors with 5,571,362 votes for, and (3) advisory vote on named executive officer compensation with 3,020,736 votes for. This directly matches Item 5.07 requirements and the shareholder_vote_results event type.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-02
Item 5.07
This Item 5.07 disclosure presents the final results of Park Dental Partners' 2026 Annual Meeting of Shareholders held on May 29, 2026, including voting outcomes for the election of Christopher C. Smith as a Class II director and the ratification of Deloitte & Touche LLP as independent auditor. The filing explicitly sets forth vote tallies (For, Against, Withheld, Abstain, Broker Non-Votes) for both proposals, which is the core content of shareholder_vote_results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-02
Item 5.07
This Item 5.07 disclosure reports the results of SL Green Realty Corp.'s Annual Meeting of Stockholders held on June 2, 2026, including voting outcomes for three proposals: election of eight directors (Proposal 1), advisory approval of executive compensation (Proposal 2), and ratification of Deloitte & Touche LLP as independent auditor (Proposal 3). The filing provides detailed vote tallies for each proposal, which is the core content required by Item 5.07 for shareholder vote results.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-02
Item 5.07
Rithm Property Trust Inc. held its 2026 Annual Meeting of stockholders on June 2, 2026, with voting results on four proposals: election of four directors, ratification of Ernst & Young LLP as auditor, an advisory vote on named executive officer compensation (which failed to receive majority support), and approval of the 2026 Omnibus Incentive Plan.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-02
Item 5.07
This Item 5.07 disclosure reports the results of ADMA Biologics' 2026 Annual Meeting of Stockholders held on June 2, 2026, including voting outcomes on three proposals: election of two Class I directors, ratification of KPMG LLP as independent auditor, and advisory approval of named executive officer compensation. The filing provides detailed vote tallies for each proposal, which is the core content of a shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-02
Item 5.07
Harvard Bioscience held its Annual Meeting on June 2, 2026, with shareholders voting on five proposals: election of directors, auditor ratification, executive compensation advisory vote, ESPP plan amendment, and incentive plan amendment. The filing discloses the voting results for all proposals.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-02
Item 5.07
This is a classic Item 5.07 disclosure of shareholder meeting results. The filing reports the outcomes of three proposals voted on at the June 2, 2026 Annual Meeting: election of four directors (Forrestel, Lounsberry, Tomson, and Tranter), approval of Named Executive Officers' compensation (Say-on-Pay), and ratification of Crowe LLP as independent auditor. All three proposals passed with substantial majorities, making this a material governance event that affects investor understanding of the company's leadership and oversight structure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-02
Item 5.07
Varonis Systems held its 2026 Annual Meeting of Stockholders on June 1, 2026, with voting results on four proposals: election of four directors, advisory vote on executive compensation, ratification of auditor appointment, and approval of an increase of 6,402,279 shares under the 2023 Omnibus Equity Incentive Plan. The filing discloses detailed vote tallies (For, Against, Abstain, Broker Non-Votes) for each proposal.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-02
Item 5.07
Gogo Inc. held its Annual Meeting of Stockholders on May 28, 2026, with shareholders voting on four proposals: election of three Class I directors (Oakleigh Thorne, Hugh W. Jones, Charles C. Townsend), advisory approval of 2025 executive compensation, approval of the Amended and Restated 2024 Omnibus Equity Incentive Plan, and ratification of Deloitte & Touche LLP as independent auditor. All proposals passed with disclosed vote tallies.
View raw filing on EDGAR →